1. Home
  2. BIAF vs ASNS Comparison

BIAF vs ASNS Comparison

Compare BIAF & ASNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • ASNS
  • Stock Information
  • Founded
  • BIAF 2014
  • ASNS 1998
  • Country
  • BIAF United States
  • ASNS United States
  • Employees
  • BIAF N/A
  • ASNS N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • ASNS Telecommunications Equipment
  • Sector
  • BIAF Health Care
  • ASNS Telecommunications
  • Exchange
  • BIAF Nasdaq
  • ASNS Nasdaq
  • Market Cap
  • BIAF 7.1M
  • ASNS 6.7M
  • IPO Year
  • BIAF 2022
  • ASNS 2022
  • Fundamental
  • Price
  • BIAF $0.24
  • ASNS $0.43
  • Analyst Decision
  • BIAF Hold
  • ASNS Strong Buy
  • Analyst Count
  • BIAF 1
  • ASNS 1
  • Target Price
  • BIAF N/A
  • ASNS $5.00
  • AVG Volume (30 Days)
  • BIAF 468.1K
  • ASNS 8.6M
  • Earning Date
  • BIAF 08-14-2025
  • ASNS 08-14-2025
  • Dividend Yield
  • BIAF N/A
  • ASNS N/A
  • EPS Growth
  • BIAF N/A
  • ASNS N/A
  • EPS
  • BIAF N/A
  • ASNS N/A
  • Revenue
  • BIAF $7,681,059.00
  • ASNS $5,265,000.00
  • Revenue This Year
  • BIAF N/A
  • ASNS N/A
  • Revenue Next Year
  • BIAF $20.00
  • ASNS $104.77
  • P/E Ratio
  • BIAF N/A
  • ASNS N/A
  • Revenue Growth
  • BIAF 4.99
  • ASNS N/A
  • 52 Week Low
  • BIAF $0.16
  • ASNS $0.34
  • 52 Week High
  • BIAF $2.26
  • ASNS $1.83
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 39.54
  • ASNS 43.67
  • Support Level
  • BIAF $0.24
  • ASNS $0.34
  • Resistance Level
  • BIAF $0.26
  • ASNS $0.48
  • Average True Range (ATR)
  • BIAF 0.02
  • ASNS 0.06
  • MACD
  • BIAF 0.00
  • ASNS -0.00
  • Stochastic Oscillator
  • BIAF 17.02
  • ASNS 32.72

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About ASNS Actelis Networks Inc.

Actelis Networks Inc is a networking solutions company with a mission to enable communication for Internet of Things, or IoT, projects, deployed over wide areas such as cities, campuses, airports, military bases, roads, and rail. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create a cost-effective, secure, and quick-to-deploy network. Its solutions also offer end-to-end network security to protect critical IoT data, utilizing a powerful combination of coding and encryption technologies, applied as required on both new and existing infrastructure within the hybrid-fiber-copper network. The company operates as one operating segment: developing and marketing access broadband equipment for copper and fiber networks.

Share on Social Networks: